This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Menglu Zhao - Innovator in Cancer Treatment
Introduction
Menglu Zhao is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on developing targeted therapies that can improve cancer diagnosis and treatment.
Latest Patents
Menglu Zhao holds a patent for a pentapeptide associated with integrin receptor αvβ3. This pentapeptide has a specific sequence of arginine-tryptophan-arginine-asparagine-methionine. It is designed to target tumor cells that highly express the αvβ3 receptor, while sparing those that express it at lower levels and normal cells. This innovation is particularly useful in the diagnosis and treatment of various cancers.
Career Highlights
Menglu Zhao is affiliated with China Pharmaceutical University, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.
Collaborations
Menglu Zhao collaborates with notable colleagues, including Yueqing Gu and Congying Zhang. Their combined expertise enhances the research efforts and contributes to the advancement of cancer treatment methodologies.
Conclusion
Menglu Zhao's innovative work in developing targeted cancer therapies highlights her significant role in the field of medical research. Her contributions are paving the way for more effective cancer treatments and improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile